TECH-MAHINDRA
19.9.2023 16:35:36 CEST | Business Wire | Press release
Tech Mahindra, a leading provider of digital transformation, consulting, and business re-engineering services & solutions, today inaugurated a local innovation centre in Espoo, Finland. This expansion comes after a sustained period of growth in the region and signifies Tech Mahindra’s commitment to further its journey in Finland, and the Nordic region. The new centre will accommodate a diverse workforce – increasing the in-country headcount ranging from experienced business leaders to fresh talent, in collaboration with the local ecosystem.
Located in Espoo, a part of the greater Helsinki metropolitan area, the new centre situates Tech Mahindra at the heart of one of the major business hotspots and innovation hubs in the Nordics. From this strategic location, Tech Mahindra will continue to provide digital business transformation services and solutions to customers.
Mohit Joshi, Managing Director and CEO Designate of Tech Mahindra, said, “Given its focus on innovation, sustainability, and a unique approach to entrepreneurship; today Finland ranks amongst the topmost countries in the world that leverage emerging technologies to shape the future business landscape. This is also reflected in Tech Mahindra’s commitment to the ongoing expansion in the Nordics region, and the establishment of our new centre in Espoo. It is our endeavor to widen the talent pool, fuel innovation, improve agility to deliver robust solutions, and be closer to our customers’ businesses to drive sustainable growth.”
The inauguration ceremony was attended by dignitaries such as Raveesh Kumar, Ambassador of India to Finland; Jusa Susia, Senior Director & Head of Region East Asia & India at Business Finland; and Janne Kari, Head of Industry, ICT and Digitalisation at Invest in Finland. Tech Mahindra representatives include CP Gurnani, Managing Director and CEO; Mohit Joshi, Managing Director and CEO Designate; Mukul Dhyani, Senior Vice President & Business Head Continental Europe; Rajesh Barwal, VP & Country Manager for Sweden and Finland; C-H Hallstrom, Vice President, Strategic Programs, Nordics.
Further to the commitment in 2022 to set up a Makers Lab, Tech Mahindra’s research and development arm in Finland, the newly opened centre will also facilitate innovation in collaboration with new and existing customers in the region. The team will work on new and emerging technologies such as Quantum computing, Generative AI and Metaverse. The Makers Lab will also plug into the local startup ecosystem and universities to provide new opportunities in R&D across industries.
In the ten years since Tech Mahindra entered the Finnish market, the organisation has firmly established itself as a leading business transformation expert in the region. By leveraging deep industry expertise and long-term experience in tailoring and deploying best-in-class solutions, Tech Mahindra continues to help businesses to navigate the complex challenges present in the modern business landscape.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919543874/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SES Announces Extraordinary General Meeting of Shareholders15.5.2026 08:30:00 CEST | Press release
SES: Société Anonyme RCS Luxembourg B 81267 Notice is hereby given of the Extraordinary General Meeting of SES, Société Anonyme, to be held at the Company's registered office at Château de Betzdorf, L-6815 Betzdorf (the "Company"), Luxembourg, on Wednesday 17 June 2026 at 3:00 p.m. CET AGENDA Attendance list, quorum and adoption of the agenda Nomination of a secretary and of two scrutineers Cancellation of shares purchased in connection with the buy-back programme of 2 November 2023, as amended on 2 May 2024, in accordance therewith and pursuant thereto - Reduction of the share capital in accordance with article 450-5 of the law of 10 August 1915 on commercial companies, as amended, by forty-four million nine hundred ten thousand seven hundred eighty euro (EUR 44,910,780) through the cancellation of thirty-five million nine hundred and twenty-eight thousand six hundred and twenty-four (35,928,624) shares divided into (i) twenty-three million nine hundred and fifty-two thousand four hun
Experian Partners With ServiceNow to Scale Trusted Decisioning to Agentic AI15.5.2026 08:00:00 CEST | Press release
New global long‑term partnership embeds Experian’s Ascend capabilities directly into ServiceNow workflows, transforming client operations Experian, the global data and technology company, and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today unveil a new global multi-year partnership which harnesses the power of autonomous AI agents across platforms, helping businesses make faster and smarter decisions at scale. Through this partnership, autonomous AI agents can gain the ability to act faster, and more consistently, starting with employee onboarding, third-party risk management and model life cycle governance use cases. A major challenge for global organisations adopting agentic AI is achieving scale, with deployments often constrained by a lack of trusted data. In fact, industry research shows that data limitations are the primary barrier for eight in ten organisations. By connecting trusted intelligence directly into enterprise workflows, this partnership e
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet15.5.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III clinical trials evaluating the efficacy and safety of its novel β-lactamase inhibitor nacubactam (development code: OP0595), have been published in The Lancet. The article is entitled “---Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial” (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00596-9/fulltext) Integral-1 is a global, double-blind, randomized Phase III trial (jRCT2031230075) in patients with complicated urinary tract infection or acute uncomplicated pyelonephritis that compared the efficacy and safety of nacubactam co-administered with either cefepime or aztreonam versus imipenem-c
Boomi Teams up With Gong to Bring Revenue AI to Boomi Agentstudio14.5.2026 18:00:00 CEST | Press release
Gong's revenue AI is now natively available in the Boomi Enterprise Platform Boomi, the data activation company for AI, today announced a collaboration withGong, the leader in Revenue AI, to bring revenue signals captured in Gong natively into the Boomi Enterprise Platform. This collaboration enables enterprises to establish an active data foundation designed to transform customer conversations into coordinated, automated actions across systems and functions enterprise-wide with Boomi Agentstudio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514443012/en/ Boomi Teams Up with Gong to Bring Revenue AI to Boomi Agentstudio Gong goes beyond capturing deal activity to surface real-time insights into risk, buyer intent, competitive dynamics, and key engagement signals. That intelligence moves from conversation to coordinated action, flowing across CRM, ERP, product, and operational systems with the governance and security tha
Xsolla and Skich Announce Strategic Partnership to Bring Merchant of Record Payments to an Alternative Mobile Game Marketplace14.5.2026 18:00:00 CEST | Press release
Partnership Enables Developers To Monetize Games On The Skich Store With Xsolla Handling Payments, Tax Compliance, And Commerce Infrastructure Xsolla, a leading global video game commerce company, today announced a strategic partnership with Skich, an alternative mobile game marketplace operating on iOS in the EU under Apple's Digital Markets Act provisions and on Android globally. Under the agreement, Xsolla will serve as Merchant of Record for in-app purchases and paid game sales distributed through the Skich Store. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514867730/en/ Graphic: Xsolla Skich serves as an alternative to traditional mobile storefronts, offering developers a way to reach players outside platform-controlled distribution channels. The partnership with Xsolla enables Skich to offer a fully compliant payment and commerce layer, with Xsolla managing payment processing, tax collection, refunds, and regulat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom